Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety

OBJECTIVE: To assess the effects of onabotulinumtoxinA treatment for chronic migraine (CM) on comorbid symptoms of depression, anxiety, fatigue and poor sleep quality. METHODS: The Chronic Migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) study is a multicentre, open-label, prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Blumenfeld, Andrew M, Tepper, Stewart J, Robbins, Lawrence D, Manack Adams, Aubrey, Buse, Dawn C, Orejudos, Amelia, D Silberstein, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Migraine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518474/
https://www.ncbi.nlm.nih.gov/pubmed/30630956
http://dx.doi.org/10.1136/jnnp-2018-319290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518474/
https://www.ncbi.nlm.nih.gov/pubmed/30630956
http://dx.doi.org/10.1136/jnnp-2018-319290

Ejemplares similares